Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandra Jimenez-Falcao has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Delivering Proteins and Enzymes to Solid Tumors Through the Development of Stimuli‐Responsive Nanocarriers

    by Guillermo Plaza‐Palomo, Diana Benita‐Donadios, Sandra Jiménez‐Falcao, Alejandro Baeza

    Proteins, enzymes, and peptides have long been recognized as valuable therapeutic agents, particularly in oncology. However, their complex chemical structures render them more sensitive than smaller chemotherapeutic drugs. As a result, their administration and pharmacokinetics have been the subject of extensive research to overcome limitations associated with premature clearance and degradation. The pharmaceutical industry has come up with various solutions, such as partial modification of their structure or their incorporation into targeted drug carrier systems. In this context, the advancement of nanotechnology has offered a promising strategy for the efficient delivery of these sensitive yet potent biopharmaceuticals to solid tumors, while enabling control of their action in response to specific stimuli. The versatility of nanoscience has endowed these nanovehicles with an expanding array of tailored features, enhancing their capabilities through controlled chemical composition and surface functionalization, and optimizing their interaction with both the immune system and the tumor microenvironment. This review compiles cutting‐edge research articles to explore the full potential of stimuli‐responsive nanocarriers in protein‐based cancer treatment, categorizing nanosystems based on their organic (polymeric, lipidic, protein) or inorganic (metallic, silica‐based, metal–organic framework) composition. Design principles and therapeutic performances are discussed, and emerging directions for next‐generation nanomedicine are highlighted.


  • Open Access

    Low-Cost Versatile Microfluidic Platform for Bioorthogonal Click-Mediated Nanoassembly of Hybrid Nanosystems

    by Javier González-Larre, María Amor García del Cid, Diana Benita-Donadios, Ángel Vela-Cruz, Sandra Jiménez-Falcao, Alejandro Baeza

    In recent years the global market of nanomedicine has experienced incredible growth owing to the advances in the field. This translation of the technique to the biomedical industry requires the development of production methods that deliver nanomedicines with a high degree of reproducibility between batches, combined with cost and time efficiency. The use of nanoparticles in medicine usually requires their surface functionalization to improve biocompatibility in addition to providing targeting capacities and/or stimuli-responsive behavior, among other interesting skills. Microfluidic technology has revolutionized the field both in nanomedicine synthesis and in preclinical evaluation. However, microfluidic-assisted synthetic procedures commonly require high-cost methods and equipment to fabricate the microreactors. The aim of this work is to present an ultra-low-cost microfluidic platform that permits the versatile modification of nanomaterials. To prove this approach, two different model nanoparticles with different natures: soft nanoparticles (liposomes) and rigid nanoparticles (mesoporous silica) have been decorated both with small molecules and with other nanoparticles, respectively, in order to evaluate the scope of this approach. The anchoring of the covalently attached elements has been performed using click chemistry, in compliance with the principles for further transfer to the drug industry.

  • Open Access

    Sialic Acid and Colchicine Functionalized Silica Nanoparticles: A Novel Approach to Leishmanicidal Selective Treatments

    by Adan Jesus Galue-Parra, Sandra Jimenez-Falcao, Esther Arribas-Yuste, Clotilde Marin, Jose Manuel Mendez-Arriaga

    Background/Objectives: Leishmaniasis remains a neglected tropical disease, with nearly one million new cases annually and limited investment in research. Current treatments, primarily based on pentavalent antimonials, are associated with severe side effects and increasing resistance. This study aims to develop a novel therapeutic strategy using a nanomaterial functionalized with sialic acid (SA) and colchicine (COL) to selectively target Leishmania braziliensis parasites. Methods: A nanostructured system was engineered by functionalizing its surface with SA and COL. SA was chosen to mimic host cell surfaces, enhancing parasite attraction, while COL was selected for its known leishmanicidal properties. The nanomaterial was designed to concentrate extracellular parasites on its surface via SA-mediated interactions, thereby increasing local COL efficacy. Results: The functionalized nanomaterial demonstrated a dual mechanism: SA facilitated the selective accumulation of Leishmania braziliensis parasites on the nanostructure surface, while COL exerted a cytotoxic effect. This synergistic interaction resulted in enhanced parasite mortality in vitro, suggesting improved selectivity and potency compared to conventional treatments. Conclusions: The proposed nanomaterial offers a promising alternative for leishmaniasis treatment by combining targeted parasite attraction with localized drug delivery. This strategy may reduce systemic toxicity and improve therapeutic outcomes.


  • Open Access

    Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy

    by Alicia Arroyo-Nogales, Guillermo Plaza-Palomo, Javier González-Larre, Sandra Jiménez-Falcao, Alejandro Baeza

    The use of nanoparticles as drug carriers in oncology has evolved from their traditional role as chemotherapy carriers to their application in immunotherapy, exploiting not only their passive accumulation in solid tumors but also their ability to interact with immune cells. Silicasomes are highly versatile nanoplatforms composed of a mesoporous silica core whose external surface is coated with a lipid bilayer that allows the co-delivery of therapeutic agents having different chemical natures (small molecules, proteins, enzymes, or oligonucleotides, among others). Herein, cutting-edge advances carried out in the development and application of silicasomes are presented, providing a general description of the performance of these nanotransporters. Additionally, the specific load of chemotherapeutic drugs is explored, followed by a discussion of the immunotherapeutic application of silicasomes and the combination of different therapeutic strategies, including theragnosis, in a single silicasome platform, highlighting the enormous potential of these nanosystems.


  • Open Access

    Recent Advances in Metal Complexes Based on Biomimetic and Biocompatible Organic Ligands against Leishmaniasis Infections: State of the Art and Alternatives

    by Sandra Jimenez-Falcao, Jose Manuel Mendez-Arriaga

    Leishmaniasis is a complex disease present in a variety of manifestations listed by the World Health Organization (WHO) as one of the neglected diseases with a worse prognosis if not treated. Medicinal inorganic chemistry has provided a variety of drugs based on metal–organic complexes synthesized with different metal centers and organic ligands to fight against a great number of parasite maladies and specifically Leishmaniasis. Taking advantage of the natural properties that many metals present for biotechnological purposes, nanotechnology has offered, in recent years, a new approach consisting on the application of metal nanoparticles to treat a great number of parasitic diseases, as a drug vehicle or as a treatment themselves. The aim of this review is to gather the most widely used metal complexes and metallic nanoparticles and the most recent strategies proposed as antileishmanial agents.


  • Open Access

    First-Row Transition 7-Oxo-5-phenyl-1,2,4-triazolo[1,5-a]pyrimidine Metal Complexes: Antiparasitic Activity and Release Studies

    by Álvaro Martín-Montes, Sandra Jimenez-Falcao, Santiago Gómez-Ruiz, Clotilde Marín, José M. Mendez-Arriaga

    Leishmaniasis and Chagas disease are still considered neglected illnesses due to the lack of investment in research, despite the fact that almost one million new cases are reported every year. Four 7-oxo-5-phenyl-1,2,4-triazolo[1,5-a]pyrimidine (HftpO) first-row transition complexes (Cu, Co, Ni, Zn) have been studied for the first time in vitro against five different species of Leishmania spp. (L. infantum, L. braziliensis, L. donovani, L. peruviana and L. mexicana) as well as Trypanosoma cruzi, showing higher efficacy than the reference commercial drugs. UV and luminescence properties were also evaluated. As a proof of concept, anchoring of a model high-effective-metal complex as an antiparasitic agent on silica nanoparticles was carried out for the first time, and drug-release behaviour was evaluated, assessing this new approach for drug vehiculation.


  • Dithioacetal-mechanized mesoporous nanosensor for Hg(II) determination

    by Sandra Jimenez-Falcao, Anabel Villalonga, Jorge Parra-Nieto, Antoni Llopis-Lorente, Paloma Martinez-Ruiz, Ramón Martinez-Mañez, Reynaldo Villalonga


  • Reduced graphene oxide-carboxymethylcellulose layered with platinum nanoparticles/PAMAM dendrimer/magnetic nanoparticles hybrids. Application to the preparation of enzyme electrochemical biosensors

    by Boryana Borisova, Alfredo Sánchez, Sandra Jiménez-Falcao, Miriam Martín, Pedro Salazar, Concepción Parrado, José M. Pingarrón, Reynaldo Villalonga


  • Novel reduced graphene oxide–glycol chitosan nanohybrid for the assembly of an amperometric enzyme biosensor for phenols

    by Abderrahmane Boujakhrout, Sandra Jimenez-Falcao, Paloma Martínez-Ruiz, Alfredo Sánchez, Paula Díez, José M. Pingarrón, Reynaldo Villalonga

    A novel water-soluble graphene derivative was prepared from graphene oxide via a two-step modification approach. Graphene oxide was first functionalised with reactive epoxy groups by covalent modification with (3-glycidyloxypropyl)trimethoxysilane and further cross-linked with glycol chitosan. This graphene derivative was characterized using different microscopy and physicochemical methods and employed as a coating material for a glassy carbon electrode. The nanostructured surface was used as a support for the covalent immobilization of the enzyme laccase through cross-linking with glutaraldehyde. The enzyme electrode was tested for the amperometric detection of different phenolic compounds, which displayed excellent analytical behaviour toward catechol with a linear range of response from 200 nM to 15 μM, sensitivity of 93 mA M−1 cm−2, and low detection limit of 76 nM. The enzyme biosensor showed high stability when stored at 4 °C under dry conditions and was successfully employed to quantify the total phenolic compounds in commercial herbal tea samples.


  • Decorating graphene oxide/nanogold with dextran-based polymer brushes for the construction of ultrasensitive electrochemical enzyme biosensors

    by Abderrahmane Boujakhrout, Alfredo Sánchez, Paula Díez, Sandra Jiménez-Falcao, Paloma Martínez-Ruiz, Miriam Peña-Álvarez, José M. Pingarrón, Reynaldo Villalonga

    A novel strategy was employed to prepare a water-soluble graphene derivative by using dextran-based polymer brushes as solubilizing agents. Graphene oxide was grafted with (3-mercaptopropyl) trimethoxysilane and further decorated with Au nanoparticles. This hybrid nanomaterial was then reduced and anchored with polysaccharide-based polymer brushes by chemisorption of an end-group thiolated dextran derivative on the Au nanoparticles. The resulting hybrid nonmaterial allowed highly stable aqueous dispersions to be obtained, which were used to coat glassy carbon electrodes for the preparation of a model tyrosinase electrochemical biosensor for catechol. The enzyme electrode showed excellent electroanalytical performance with fast response in about 5 s, a linear range of 100 pM–120 nM, a very high sensitivity of 45.9 A M−1 and a very low detection limit of 40 pM for catechol.